期刊文献+

帕金森病患者睡眠障碍的临床特征及影响因素分析 被引量:1

Analysis of Clinical Features and Influential Factors of Sleep Disorders in Patients with Parkinson's Disease
下载PDF
导出
摘要 [目的]探讨帕金森病(PD)睡眠障碍发生的相关临床因素.[方法]选取本院门诊及住院的PD患者76例,记录所有PD患者的年龄、性别、使用多巴丝肼剂量、受教育程度,并对所有PD患者行帕金森病评价量表(UPDRS)、Hoehn Yahr(H-Y)分期、疲劳严重度量表(FSS)评分、汉密尔顿抑郁(HAMD)评分、匹兹堡睡眠质量指数评分(PSQI)、爱泼沃斯嗜睡量表(ESS)等评分,根据患者有无睡眠障碍将PD患者分为睡眠障碍组与非睡眠障碍组,分别比较两组患者的临床资料并利用Spearman分析探讨PD患者睡眠障碍发生的相关因素.[结果]76例PD患者中,48例存在睡眠障碍,发生率为63.2%,PD睡眠障碍组患者UPDRS评分、H-Y分期、FSS评分、多巴丝肼剂量、HAMD评分明显高于非障碍组患者,且两组相比较差异均有显著性(均P <0.05).PD患者睡眠障碍的发生与UPDRS评分、H-Y分期,FSS评分、多巴丝肼剂量、HAMD评分有关(r =0.56~0.81,均P<0.05),而与性别、年龄、病程、受教育程度无关.[结论]PD患者的睡眠障碍发生率较高,影响因素较多,值得在临床工作中加以重视. [Objective]To explore the related factors of sleep disorders in patients with Parkinson's disease (PD).[Methods] A total of 76 patients with PD in our hospital were chosen.The age,gender,dose of Madopar and education level of patients with PD were recorded.In addition,unified Parkinson's disease rating scale (UPDRS),Hoehn-Yahr(H-Y) stage,fatigue severity scale(FSS) score,Hamilton depression scale(HAMD) score,Pittsburgh sleep quality index(PSQI) and Epworth sleepiness scale (ESS) were used in PD patients.According to with or without sleep disorder,all patients with PD were divided into sleep disorder group and non-sleep disorder group.Clinical data were analyzed and compared between two groups.Spearman analysis was used to discuss the related factors of sleep disorder in PD patients.[Results] Among 76 patients,48 patients had sleep disorders,and the incidence rate was 63.2%.UPDRS scores,H-Y stage,FSS scores,Madopar dosage and depression scores in PD with sleep disorder group were obviously higher than those in PD without sleep disorder group,and there were significant differences between two groups(all P <0.05).Sleep disorder in PD patients was associated with UPDRS,H-Y stage,FSS scores,Madopar dosage and depression scores(r =0.56~0.81,all P <0.05),but not correlated with gender,age,disease duration and education level.[Conclusion] The incidence rate of sleep disorders in PD patient is high and has various influential factors.Therefore,it should be emphasized in clinical practice.
出处 《医学临床研究》 CAS 2014年第9期1665-1666,1669,共3页 Journal of Clinical Research
基金 国家自然科学基金(81301077),江苏省高校自然科学基金资助项目(13KJB320026)
关键词 帕金森病 睡眠障碍 Parkinson Disease Sleep Disorders
  • 相关文献

参考文献10

  • 1Devine MJ, Gwinn K, Singleton A, et al . Parkinson's dis ease and a-synuclein expression[J]. Mov Disord, 2011, 26 (18) :2160-2168.
  • 2Yu R, Liu B, Wang L, et al . Enhanced functional connectiv- ity between putamen and supplementary motor area in Par- kinson's disease patients[J]. PLoS One, 2013, 8 : e59717.
  • 3Mahale R. Rapid eye movement sleep behaviour disorder in young- and older-onset Parkinson disease= a questionnaire- based study[J]. Sleep Med, 2014, 15(6) :642-646.
  • 4Sdez-Francds N, Herndndez Vara J, Corominas-Roso M, et al. Relationship between poor decision making process and fatigue perception in Parkinson's disease patients [J]. JNeurol Sci, 2014, 337(1 2) :167-172.
  • 5Miguelez C, Morera Herreras T, Torreeilla M, et al . Inter- action between the 5-HT system and the basal ganglia: func- tional implication and therapeutic perspective in Parkinson's disease[J]. Front Neural Circuits, 2014, 8(1) :21.
  • 6严金柱,季晓林,叶华,林细康.帕金森病患者睡眠障碍的多导睡眠图、多次睡眠潜伏期试验分析[J].中华神经科杂志,2011,44(8):528-532. 被引量:11
  • 7Schrempf W. Sleep disorders in Parkinson's disease[J]. J Parkinsons Dis, 2014, 4(2) :211-221.
  • 8何跃(综述),刘莹(综述),张春驰(综述),王苏(审校).帕金森病药物治疗的现状[J].中国医师杂志,2008,10(4):566-568. 被引量:6
  • 9Goldman JG, Holden S. Treatment of psychosis and demen- tia in Parkinson's disease[J]. Curr Treat Options Neurol, 2014, 16(3):281.
  • 10Peppe A, Pierantozzi M, Baiamonte V, et al. Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one- year follow-up[J]. Sleep, 2012, 35(12) : 1637-1642.

二级参考文献39

  • 1刘姝,陈彪,蔡彦宁,李丽萍,王玉平.帕金森病患者的睡眠异常[J].中华神经科杂志,2006,39(3):193-195. 被引量:8
  • 2邓顺周,李润铭.帕金森病治疗药物[J].食品与药品,2007,9(05A):28-31. 被引量:3
  • 3陈茹.帕金森病研究进展[J].中国康复理论与实践,2007,13(7):637-639. 被引量:14
  • 4胡喜庆,张本恕.帕金森病患者睡眠障碍的多导睡眠图研究[J].中华神经科杂志,2007,40(7):471-474. 被引量:5
  • 5Singh N, Pillay V, Choonara-YE. Advancis in the treatment of Parkinson's disease. Prog-Neumbiol, 2007, 8(1): 29-44.
  • 6Braak H , Del Tredici K , Rub U , et al . Staging of brain pathology related to sporadic Parkingson's disease. Neurobiol Aging, 2003, 24:197- 211.
  • 7Anthony EL. The progression of Parkinson disease. Neurology, 2007, 68 : 948-952 .
  • 8Pahwa R. Understanding parkinson's disease : an update on current diagnostic and treatment strategies. J Am Med Dir Assoc, 2006, 7 (7Suppl 2) : 4-10.
  • 9Holloway RG, Shoulson I, Fahn S, et al. Pramipexole vs levodopa as initial treatment for Parkinson's disease: a 4-year randomized controlled trial. Arch Neural, 2004, 61:1044-1053.
  • 10Stocchi F, Vacca L, BerardeUi A, et al. Duol dopamine against treat- ment in Parkinson's disease. J Neurol, 2003, 250:822-826.

共引文献15

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部